Skip to content

Shares (Diluted) at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
27M-3.6%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
29M-7.2%
IQVIA logo
IQVIAIQV
169.8M-4.3%
TEC
Bio-TechneTECH
157.4M-1.0%
Danaher logo
DanaherDHR
711.2M-1.3%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's shares (diluted)?
Charles River Laboratories (CRL) reported shares (diluted) of 49M in Q1 2026.
How has Charles River Laboratories's shares (diluted) changed year-over-year?
Charles River Laboratories's shares (diluted) decreased by 3.7% year-over-year, from 50.9M to 49M.
What is the long-term trend for Charles River Laboratories's shares (diluted)?
Over 4 years (2021 to 2025), Charles River Laboratories's shares (diluted) has grown at a -0.8% compound annual growth rate (CAGR), from 205.4M to 199.2M.
What does shares (diluted) mean?
The total number of shares that would exist if all potential conversion options were exercised.
How do you interpret shares (diluted)?
An increase in this number relative to basic shares indicates a higher potential for dilution of existing shareholder value.
How does shares (diluted) compare across companies?
Standard metric for all publicly traded companies.